Journal of Surgery Concepts & Practice >

2022 , Vol. 27 >Issue 04: 359 - 362

DOI: https://doi.org/10.16139/j.1007-9610.2022.04.017

Case report

Transcatheter splenic artery embolization for pancreatic sinistral portal hypertension with gastrointestinal blee-ding: a case report

Expand
  • 1. Department of Gastroenterology, Wenzhou People’s Hospital, Wenzhou Third Clinical Institute Affiliated To Wenzhou Medical University, Zhejiang Wenzhou 325000, China
    2a. Department of Interventional Therapy, Shanghai 200032, China
    2b. Department of Gastroenterology, Zhongshan Hospital, Fudan University, Shanghai 200032, China

Received date: 2021-03-05

  Online published: 2022-09-20

Fold

Abstract

Pancreatic sinistral portal hypertension (PSPH) is a rare entity resulting from splenic vein obstruction and is characterized by splenomegaly, gastric and/or esophageal varices with normal liver function. PSPH-related gastric varices is one of severe complications with high incidence and is difficult for prompt diagnosis and treatment. To date, there is no consensus on treatment strategy. Splenic artery embolization (SAE) has been considered as an alternative strategy to splenectomy with satisfactory safety and efficacy for treatment of gastric bleeding caused by PSPH. Here we reported one case with autoimmune pancreatitis-related PSPH with gastric bleeding in Department of Gastroenterology Zhongshan Hospital. Treatment with transcatheter SAE led to gradual stop of gastric bleeding and much improvement of gastric varices. Follow-up study indicated that recurrence of upper gastrointestinal bleeding was not present without postoperative complication. The results suggest that SAE is a minimally invasive, safe and effective treatment strategy for controlling PSPH-related gastric variceal bleeding in the patient with autoimmune pancreatitis.

Key words： Splenic artery embolization; Autoimmune pancreatitis; Pancreatic sinistral portal hypertension; Gastro-intestinal bleeding

Cite this article

CHEN Xiaojuan, ZHANG Wen, CAI Yu . Transcatheter splenic artery embolization for pancreatic sinistral portal hypertension with gastrointestinal blee-ding: a case report[J]. Journal of Surgery Concepts & Practice, 2022 , 27(04) : 359 -362 . DOI: 10.16139/j.1007-9610.2022.04.017

References

[1] Ono Y, Takahashi Y, Tanaka M, et al. Sinistral portal hypertension prediction during pancreatoduodenectomy with splenic vein resection[J]. J Surg Res, 2021, 259:509-515.
[2] Chen BB, Mu PY, Lu JT, et al. Sinistral portal hypertension associated with pancreatic pseudocysts - ultrasono-graphy findings: a case report[J]. World J Clin Cases, 2021, 9(2):463-468.
[3] Wei B, Zhang L, Tong H, et al. Retrospective comparison of clinical outcomes following splenic vein stenting and splenic arterial embolization in sinistral portal hypertension-related gastrointestinal bleeding[J]. Am J Roentgenol, 2021, 216(6):1579-1587.
[4] Ru N, He CH, Ren XL, et al. Risk factors for sinistral portal hypertension and related variceal bleeding in patients with chronic pancreatitis[J]. J Dig Dis, 2020, 21(8):468-474.
[5] Kokabi N, Lee E, Echevarria C, et al. Sinistral portal hypertension: presentation, radiological findings, and treatment options - a case report[J]. J Radiol Case Rep, 2010, 4(10):14-20.
[6] Liu Q, Song Y, Xu X, et al. Management of bleeding gastric varices in patients with sinistral portal hypertension[J]. Dig Dis Sci, 2014, 59(7):1625-1629.
[7] Fernandes A, Almeida N, Ferreira AM, et al. Left-sided portal hypertension: a sinister entity[J]. GE Port J Gastroenterol, 2015, 22(6):234-239.
[8] Köklü S, Coban S, Yüksel O, et al. Left-sided portal hypertension[J]. Dig Dis Sci, 2007, 52(5):1141-1149.
[9] McCormick PA, O′Keefe C. Improving prognosis follo-wing a first variceal haemorrhage over four decades[J]. Gut, 2001, 49(5):682-685.
[10] Yu X, Bai X, Li Q, et al. Role of collateral venous circulation in prevention of sinistral portal hypertension after superior mesenteric-portal vein confluence resection during pancreaticoduodenectomy: a single-center expe-rience[J]. J Gastrointest Surg, 2020, 24(9):2054-2061.
[11] Li H, Yang Z, Tian F. Clinical characteristics and risk factors for sinistral portal hypertension associated with moderate and severe acute pancreatitis: a seven-year single-center retrospective study[J]. Med Sci Monit, 2019, 25:5969-5976.
[12] Xie CL, Wu CQ, Chen Y, et al. Sinistral portal hypertension in acute pancreatitis: a magnetic resonance imaging study[J]. Pancreas, 2019, 48(2):187-192.
[13] Kumar S, Raobiakady R, Watkins D, et al. Radical resection of large metastatic non-functioning pancreatic neuroendocrine carcinoma complicated by splenic vein thrombosis and sinistral portal hypertension[J]. Int J Surg Case Rep, 2021, 81:105724.
[14] Covello B, Miller J, Fourzali R. Splenic vein stenting for recurrent chylous ascites in sinistral portal hypertension: a case report[J]. CVIR Endovasc, 2021, 4(1):26.
[15] Wang Q, Xiong B, Zheng C, et al. Splenic arterial embolization in the treatment of severe portal hypertension due to pancreatic diseases: the primary experience in 14 patients[J]. Cardiovasc Intervent Radiol, 2016, 39(3):353-358.
[16] Li ZY, Li B, Wu YL, et al. Acute pancreatitis associated left-sided portal hypertension with severe gastrointestinal bleeding treated by transcatheter splenic artery embolization: a case report and literature review[J]. J Zhejiang Univ Sci B, 2013, 14(6):549-554.
[17] Singhal D, Kakodkar R, Soin AS, et al. Sinistral portal hypertension. a case report[J]. JOP, 2006, 7(6):670-673.
[18] 艾敏, 卢光明, 许健. 脾动脉栓塞术在胰源性门静脉高压中的应用1例[J]. 介入放射学杂志, 2019, 28(4):366-368.
Options
Outlines

/

〈 〉